Experimental drug may help fight multiple sclerosis

The drug, Laquinimod, is still experimental, but experts say having a pill available would make therapy much more convenient for patients.

Currently approved drugs that target the inflammation associated with multiple sclerosis are all given by injection.

Laquinimod works by binding to receptors or immune cells. The study is published in the latest edition of 'The Lancet.'

Copyright © 2023 WLS-TV. All Rights Reserved.